KeyBanc
https://www.key.com/html/LP-KBCM.htmlKeyBanc Capital Markets, a subsidiary of KeyCorp (NYSE: KEY), provides investment banking and capital markets services to middle-market companies.
-
KeyBanc Remains Positive on Life Sciences as 'Strong' Earning Season Begins with Danaher (DHR) Report
-
Maravai LifeSciences Announces March 2022 Investor Conference Schedule
-
Maravai LifeSciences Announces March 2022 Investor Conference Schedule
-
Maravai LifeSciences (MRVI) Prices 20M Share Secondary Offrering at $50/sh
-
Maravai LifeSciences Announces Pricing of Secondary Offering of Class A Common Stock by Selling Stockholders
-
Maravai LifeSciences Announces Pricing of Secondary Offering of Class A Common Stock by Selling Stockholders
-
Maravai LifeSciences Announces Closing of Secondary Offering of Class A Common Stock by Selling Stockholders and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Maravai LifeSciences Announces Closing of Secondary Offering of Class A Common Stock by Selling Stockholders and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Maravai LifeSciences (MRVI) Prices 18M Share Secondary Offering at $31.25
-
Maravai LifeSciences Announces Pricing of an Upsized Secondary Offering of Class A Common Stock by Selling Stockholders
-
Maravai LifeSciences Announces Pricing of an Upsized Secondary Offering of Class A Common Stock by Selling Stockholders
-
Maravai LifeSciences Announces March 2021 Investor Conference Schedule
-
Maravai LifeSciences Announces March 2021 Investor Conference Schedule
-
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Maravai LifeSciences (MRVI) IPO Opens 18% Higher
-
Maravai LifeSciences Holdings Inc. (MRVI) Prices 60M Class A Share Upsized IPO at $27/Sh
-
Maravai LifeSciences Announces Pricing of an Upsized Initial Public Offering

